Novo Nordisk's experimental obesity drug CagriSema shows blood pressure benefits US$ 27.47 Min. order: 1 piece ★★★★★ 4.9 (169 reviews) Sold : Login>>
Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product' – NBC Connecticut US$ 20.10 Min. order: 1 piece ★★★★★ 4.7 (97 reviews) Sold : Login>>
Peptide Tools & Guides – Atlas Nutrition US$ 21.65 Min. order: 1 piece ★★★★★ 4.4 (214 reviews) Sold : Login>>
Novo Nordisk presents phase 3 data for next-generation amylin cagrilintide, leading to advancement into dedicated clinical programme US$ 27.05 Min. order: 1 piece ★★★★★ 4.9 (201 reviews) Sold : Login>>
VisualAbstract: Cagrilintide-Semaglutide is Effective for Weight Loss in Adults with Overweight or Obesity and Type 2 Diabetes US$ 25.71 Min. order: 1 piece ★★★★★ 4.0 (115 reviews) Sold : Login>>